KALA BIO, Inc. (KALA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by KALA BIO, Inc. on December 19, 2025. The report discloses significant corporate governance changes, specifically regarding the company's independent registered public accounting firm and the Board of Directors, in connection with the upcoming 2025 Annual Meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate events and does not contain financial performance data.
Material Changes
- Change in Certifying Accountant: The Audit Committee approved the dismissal of Deloitte & Touche LLP (previously disclosed on December 16, 2025) and the engagement of HTL International, LLC ("HTL") as the new independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Board Resignations: Six directors (Marjan Farid, M.D., Andrew I. Koven, C. Daniel Myers, Todd Bazmore, Mark Iwicki, and Howard B. Rosen) tendered conditional resignations effective immediately after the 2025 Annual Meeting.
- Conditions for Resignations: The resignations are contingent upon stockholder approval of two specific proposals: (i) the issuance of common stock upon conversion of certain preferred stock (Proposal 4) and (ii) an amendment to the Restated Certificate of Incorporation to increase authorized common shares (Proposal 5).
Guidance, Outlook, and Risks
Management stated that the director resignations were not due to any disagreement with the Company regarding operations, policies, or practices. David Lazar is expected to remain a Class II director regardless of the outcome of the proposals. The filing notes that no consultations regarding accounting principles or disagreements occurred between the Company and the new auditor, HTL, during the two most recent fiscal years and the subsequent interim period.
Key Facts for Investor Verification
- Verify the outcome of the 2025 Annual Meeting regarding Proposal 4 (preferred stock conversion) and Proposal 5 (authorized share increase), as these determine if the six director resignations take effect.
- Confirm the transition timeline and scope of work for the new auditor, HTL International, LLC, replacing Deloitte & Touche LLP.
- Review the Preliminary Proxy Statement filed on December 19, 2025, for detailed terms of the preferred stock conversion and capital structure changes.
- Monitor the composition of the Board of Directors post-annual meeting, noting that David Lazar is expected to remain.